These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31642644)

  • 1. The Emergence of New Psychoactive Substance (NPS) Benzodiazepines. A Survey of their Prevalence in Opioid Substitution Patients using LC-MS.
    Mc Namara S; Stokes S; Nolan J
    Ir Med J; 2019 Aug; 112(7):970. PubMed ID: 31642644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous identification of abused drugs, benzodiazepines, and new psychoactive substances in urine by liquid chromatography tandem mass spectrometry.
    Lee HH; Lee JF; Lin SY; Chen BH
    Kaohsiung J Med Sci; 2016 Mar; 32(3):118-27. PubMed ID: 27106001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022.
    Syrjanen R; Greene SL; Weber C; Smith JL; Hodgson SE; Abouchedid R; Gerostamoulos D; Maplesden J; Knott J; Hollerer H; Rotella JA; Graudins A; Schumann JL;
    Int J Drug Policy; 2023 Dec; 122():104245. PubMed ID: 37944339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
    Heikman P; Sundström M; Pelander A; Ojanperä I
    Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of a multi-component LC-MS/MS method for determination of designer benzodiazepines in urine.
    Pettersson Bergstrand M; Helander A; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1035():104-110. PubMed ID: 27697727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
    Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; Socías ME
    Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.
    Bonnet U; Specka M; Kanti AK; Scherbaum N
    Front Psychiatry; 2022; 13():1041762. PubMed ID: 36465301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Agents of Substance Use/Misuse.
    Michienzi AE; Borek HA
    Emerg Med Clin North Am; 2022 May; 40(2):265-281. PubMed ID: 35461623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.
    Helander A; Beck O; Hägerkvist R; Hultén P
    Scand J Clin Lab Invest; 2013 Aug; 73(5):400-6. PubMed ID: 23692208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of use and impairment from drugs and alcohol among trauma patients: A national prospective observational study.
    Bråthen CC; Jørgenrud BM; Bogstrand ST; Gjerde H; Rosseland LA; Kristiansen T
    Injury; 2023 Dec; 54(12):111160. PubMed ID: 37944451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
    Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
    Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
    Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
    Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
    Darragh A; Snyder ML; Ptolemy AS; Melanson S
    Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City.
    Mateu-Gelabert P; Jessell L; Goodbody E; Kim D; Gile K; Teubl J; Syckes C; Ruggles K; Lazar J; Friedman S; Guarino H
    Int J Drug Policy; 2017 Aug; 46():17-27. PubMed ID: 28577506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ; Martins SS; Su MK; Ompad DC
    Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project.
    Beck O; Franzén L; Bäckberg M; Signell P; Helander A
    Clin Toxicol (Phila); 2016 Aug; 54(7):568-75. PubMed ID: 27412885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others-A Perspective of German Addiction Medicine Experts.
    Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Grigoleit T; Hermle L; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Luckhaus C; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck GA; Wodarz N; McAnally H; Scherbaum N
    Front Psychiatry; 2020; 11():592199. PubMed ID: 33192740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.